Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | ABCB1 | P08183 | 7/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18435707 | 0.99 | RAB9A (0.37) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL15004439 | 0.92 | KDM4E (0.31) | RAB9AKDM4EALDH1A1HSD17B10NPC1 | |
| SCHEMBL14000392 | 0.84 | RAB9A (0.39) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL18969202 | 0.83 | CYP1A1 (0.37) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL12025816 | 0.82 | KDM4E (0.45) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL15291777 | 0.82 | KDM4E (0.39) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL16104343 | 0.81 | RAB9A (0.40) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL15630662 | 0.81 | RAB9A (0.37) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL13014654 | 0.80 | RAB9A (0.41) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 | |
| SCHEMBL19049027 | 0.80 | RAB9A (0.36) | RAB9AKDM4EABCB1ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4282933-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE | Samsung Electronics Co., Ltd. (KR) | 2023-11-29 | — | — | EP | disclosed |
| US-10199584-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-02-05 | — | — | US | disclosed |
| US-20180047919-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
| US-20180047919-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10199584-B2 | Organometallic compound and organic light-emitting device including the same | LEF1, LAS1L, HBS1L | RAB9A 2549/4885KDM4E 1523/4885ABCB1 3517/4885 |
| US-20180047919-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LEF1, LAS1L, HBS1L | RAB9A 2549/4885KDM4E 1523/4885ABCB1 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.